← Browse by Condition
Medical Condition
muscle invasive bladder urothelial carcinoma
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2
NCT06257017 Phase 2
Recruiting
Surveillance of the Genetic Signature in Circulating Tumor DNA for Guiding Adjuvant Chemotherapy in Urothelial Carcinoma
Enrollment
20 pts
Location
Hong Kong
Sponsor
Yung NA
NCT07061964 Phase 2
Recruiting
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Enrollment
111 pts
Location
United States
Sponsor
National Cancer Institute (NCI...